MARINEMAX INC (HZO) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HZO - US5679081084 - Common Stock
27.58 USD
-0.19 (-0.68%)
27.58 USD
0 (0%)
Overall HZO gets a fundamental rating of 3 out of 10. We evaluated HZO against 122 industry peers in the Specialty Retail industry. HZO has a bad profitability rating. Also its financial health evaluation is rather negative. HZO is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year HZO was profitable.
In the past year HZO had a positive cash flow from operations.
Of the past 5 years HZO 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: HZO reported negative operating cash flow in multiple years.
1.2 Ratios
HZO has a Return On Assets of -1.28%. This is comparable to the rest of the industry: HZO outperforms 41.80% of its industry peers.
HZO has a Return On Equity (-3.38%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 3.34%, HZO perfoms like the industry average, outperforming 50.82% of the companies in the same industry.
HZO had an Average Return On Invested Capital over the past 3 years of 4.73%. This is significantly below the industry average of 12.24%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.28% | ||
| ROE | -3.38% | ||
| ROIC | 3.34% |
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
1.3 Margins
HZO has a better Operating Margin (4.46%) than 63.11% of its industry peers.
In the last couple of years the Operating Margin of HZO has declined.
HZO's Gross Margin of 32.49% is on the low side compared to the rest of the industry. HZO is outperformed by 61.48% of its industry peers.
In the last couple of years the Gross Margin of HZO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 32.49% |
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
2. Health
2.1 Basic Checks
HZO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HZO has been reduced compared to 1 year ago.
Compared to 5 years ago, HZO has about the same amount of shares outstanding.
The debt/assets ratio for HZO is higher compared to a year ago.
2.2 Solvency
HZO has an Altman-Z score of 1.83. This is not the best score and indicates that HZO is in the grey zone with still only limited risk for bankruptcy at the moment.
HZO has a Altman-Z score (1.83) which is comparable to the rest of the industry.
HZO has a debt to FCF ratio of 92.74. This is a negative value and a sign of low solvency as HZO would need 92.74 years to pay back of all of its debts.
HZO has a Debt to FCF ratio (92.74) which is in line with its industry peers.
A Debt/Equity ratio of 1.14 is on the high side and indicates that HZO has dependencies on debt financing.
With a Debt to Equity ratio value of 1.14, HZO perfoms like the industry average, outperforming 40.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 92.74 | ||
| Altman-Z | 1.83 |
ROIC/WACC0.38
WACC8.81%
2.3 Liquidity
A Current Ratio of 1.20 indicates that HZO should not have too much problems paying its short term obligations.
HZO has a Current ratio (1.20) which is in line with its industry peers.
A Quick Ratio of 0.32 indicates that HZO may have some problems paying its short term obligations.
HZO's Quick ratio of 0.32 is on the low side compared to the rest of the industry. HZO is outperformed by 68.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.32 |
3. Growth
3.1 Past
The earnings per share for HZO have decreased strongly by -59.91% in the last year.
The earnings per share for HZO have been decreasing by -24.26% on average. This is quite bad
HZO shows a decrease in Revenue. In the last year, the revenue decreased by -5.01%.
Measured over the past years, HZO shows a quite strong growth in Revenue. The Revenue has been growing by 8.87% on average per year.
EPS 1Y (TTM)-59.91%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-116.67%
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%-1.95%
3.2 Future
The Earnings Per Share is expected to grow by 50.07% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y5.9%
EPS Next 2Y39.26%
EPS Next 3Y50.07%
EPS Next 5YN/A
Revenue Next Year1.95%
Revenue Next 2Y2.98%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 32.45, the valuation of HZO can be described as expensive.
HZO's Price/Earnings ratio is a bit cheaper when compared to the industry. HZO is cheaper than 62.30% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.25. HZO is around the same levels.
The Price/Forward Earnings ratio is 30.64, which means the current valuation is very expensive for HZO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HZO is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of HZO to the average of the S&P500 Index (23.98), we can say HZO is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.45 | ||
| Fwd PE | 30.64 |
4.2 Price Multiples
89.34% of the companies in the same industry are more expensive than HZO, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as HZO.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.51 | ||
| EV/EBITDA | 5.41 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as HZO's earnings are expected to grow with 50.07% in the coming years.
PEG (NY)5.5
PEG (5Y)N/A
EPS Next 2Y39.26%
EPS Next 3Y50.07%
5. Dividend
5.1 Amount
HZO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
27.58
-0.19 (-0.68%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners97.97%
Inst Owner Change0.05%
Ins Owners2.85%
Ins Owner Change9.65%
Market Cap603.17M
Revenue(TTM)2.31B
Net Income(TTM)-31.63M
Analysts81.54
Price Target31.47 (14.1%)
Short Float %22.26%
Short Ratio13.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.75%
Min EPS beat(2)-59.12%
Max EPS beat(2)68.62%
EPS beat(4)3
Avg EPS beat(4)70.61%
Min EPS beat(4)-59.12%
Max EPS beat(4)189.48%
EPS beat(8)4
Avg EPS beat(8)16.56%
EPS beat(12)5
Avg EPS beat(12)7.14%
EPS beat(16)9
Avg EPS beat(16)12.31%
Revenue beat(2)1
Avg Revenue beat(2)-4.93%
Min Revenue beat(2)-12.47%
Max Revenue beat(2)2.61%
Revenue beat(4)2
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.01%
Revenue beat(16)9
Avg Revenue beat(16)0.51%
PT rev (1m)0%
PT rev (3m)-9.69%
EPS NQ rev (1m)-61.23%
EPS NQ rev (3m)-134.17%
EPS NY rev (1m)-4.61%
EPS NY rev (3m)-51.94%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-2.98%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-1.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.45 | ||
| Fwd PE | 30.64 | ||
| P/S | 0.26 | ||
| P/FCF | 50.51 | ||
| P/OCF | 8.28 | ||
| P/B | 0.64 | ||
| P/tB | 1.61 | ||
| EV/EBITDA | 5.41 |
EPS(TTM)0.85
EY3.08%
EPS(NY)0.9
Fwd EY3.26%
FCF(TTM)0.55
FCFY1.98%
OCF(TTM)3.33
OCFY12.07%
SpS105.59
BVpS42.85
TBVpS17.14
PEG (NY)5.5
PEG (5Y)N/A
Graham Number28.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.28% | ||
| ROE | -3.38% | ||
| ROCE | 6.94% | ||
| ROIC | 3.34% | ||
| ROICexc | 3.62% | ||
| ROICexgc | 5% | ||
| OM | 4.46% | ||
| PM (TTM) | N/A | ||
| GM | 32.49% | ||
| FCFM | 0.52% |
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
ROICexc(3y)5.21%
ROICexc(5y)12.96%
ROICexgc(3y)7.5%
ROICexgc(5y)19.19%
ROCE(3y)9.35%
ROCE(5y)16.79%
ROICexgc growth 3Y-45.93%
ROICexgc growth 5Y-23.4%
ROICexc growth 3Y-45.55%
ROICexc growth 5Y-25.45%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
F-Score5
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 92.74 | ||
| Debt/EBITDA | 7.03 | ||
| Cap/Depr | 123.41% | ||
| Cap/Sales | 2.64% | ||
| Interest Coverage | 1.33 | ||
| Cash Conversion | 47.78% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.32 | ||
| Altman-Z | 1.83 |
F-Score5
WACC8.81%
ROIC/WACC0.38
Cap/Depr(3y)139.54%
Cap/Depr(5y)177.5%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.91%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-116.67%
EPS Next Y5.9%
EPS Next 2Y39.26%
EPS Next 3Y50.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%-1.95%
Revenue Next Year1.95%
Revenue Next 2Y2.98%
Revenue Next 3Y3.37%
Revenue Next 5YN/A
EBIT growth 1Y-19.62%
EBIT growth 3Y-27.02%
EBIT growth 5Y-1%
EBIT Next Year25.8%
EBIT Next 3Y19.63%
EBIT Next 5YN/A
FCF growth 1Y113.87%
FCF growth 3Y-12.94%
FCF growth 5Y-47.23%
OCF growth 1Y383.73%
OCF growth 3Y-1.68%
OCF growth 5Y-24.9%
MARINEMAX INC / HZO FAQ
Can you provide the ChartMill fundamental rating for MARINEMAX INC?
ChartMill assigns a fundamental rating of 3 / 10 to HZO.
What is the valuation status of MARINEMAX INC (HZO) stock?
ChartMill assigns a valuation rating of 3 / 10 to MARINEMAX INC (HZO). This can be considered as Overvalued.
Can you provide the profitability details for MARINEMAX INC?
MARINEMAX INC (HZO) has a profitability rating of 3 / 10.
Can you provide the financial health for HZO stock?
The financial health rating of MARINEMAX INC (HZO) is 3 / 10.